Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 08 Jun 2026 for Xenon Pharmaceuticals Inc., €54k. Read the official filing
Filing timeline
BuySaleGillian Cannon
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Gillian Cannon: trading record in brief
This profile gathers the share dealings of Gillian Cannon across 2 companies, led by Corcept Therapeutics Inc and Xenon Pharmaceuticals Inc. Between 4 September 2025 and 5 June 2026, the trades on record add up to 4 filings.
Every open-market trade on record is a sale: 1 sale worth €54k. Outside the open market, there are 2 option exercises. 2026 to date brings no purchases and 1 sale.
Most recently, on 8 June 2026, the filings show an open-market sale worth €54k in Xenon Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gillian Cannon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,190 shares@ US$53.140.0009% mcap100.0% of flowCommon SharesSEC:0001193125-26-262671:0
2,645 sharesCommon SharesSEC:0001193125-26-256120:0
7,393 shares0Common StockSEC:0001193125-25-201561:0
11,000 shares@ US$22.99100.0% of flowCommon StockSEC:0001193125-25-198568:0
4 of 4 declarations
